CD19 and leukemia: This is even more evident against the backdrop of a recent study reporting on the successful deployment of CD19-CAR T cells against 11q23-rearranged MLL B-ALL leukemia [11,12], which is associated with a poor prognosis and preponderance in young patients [22].